• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下咽癌非手术治疗的当前适应证

The Current Indications for Non-Surgical Treatment of Hypopharyngeal Cancer.

作者信息

de Bree Remco

机构信息

Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands,

出版信息

Adv Otorhinolaryngol. 2019;83:76-89. doi: 10.1159/000492314. Epub 2019 Feb 12.

DOI:10.1159/000492314
PMID:30754041
Abstract

The management of hypopharyngeal cancer is challenging because of poor patient survival and the potential effects of treatment on breathing, voice and swallowing. In general, early stage hypopharyngeal cancer can be primarily treated by radiotherapy or conservative transoral or open surgery, whereas advanced stage hypopharyngeal cancer can be treated by non-surgical protocols if the patient has no loss of functions (dysfunctional larynx) and/or cartilage invasion (T4a). Factors to determine individualized patient treatment include resectability, tumour volume, distant metastases, comorbidity, age, patient's preference, functional imaging parameters, response on induction chemotherapy and employing functional imaging parameters performed in the pre-treatment phase and repeated in the early treatment phase when employing a non-surgical treatment strategy.

摘要

下咽癌的治疗颇具挑战性,这是由于患者生存率低,以及治疗对呼吸、发声和吞咽可能产生的影响。一般而言,早期下咽癌可主要通过放疗或保守的经口或开放手术进行治疗,而晚期下咽癌如果患者没有功能丧失(喉功能障碍)和/或软骨侵犯(T4a),则可通过非手术方案进行治疗。决定个体化患者治疗的因素包括可切除性、肿瘤体积、远处转移、合并症、年龄、患者偏好、功能成像参数、诱导化疗反应,以及在采用非手术治疗策略时,运用治疗前阶段进行的功能成像参数,并在治疗早期阶段重复进行。

相似文献

1
The Current Indications for Non-Surgical Treatment of Hypopharyngeal Cancer.下咽癌非手术治疗的当前适应证
Adv Otorhinolaryngol. 2019;83:76-89. doi: 10.1159/000492314. Epub 2019 Feb 12.
2
[Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].[诱导化疗与手术联合放疗或同步放化疗治疗晚期下咽癌的临床疗效对比分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Dec 7;53(12):918-924. doi: 10.3760/cma.j.issn.1673-0860.2018.12.009.
3
Retrospective analysis of the clinical efficacy of definitive chemoradiotherapy for patients with hypopharyngeal cancer.下咽癌患者根治性放化疗临床疗效的回顾性分析
Jpn J Clin Oncol. 2016 Apr;46(4):344-9. doi: 10.1093/jjco/hyv216. Epub 2016 Jan 29.
4
[Organ preservation in laryngeal and hypopharyngeal cancer].[喉癌和下咽癌的器官保存]
Acta Otorrinolaringol Esp. 2007 Dec;58(10):476-82.
5
Larynx preservation: what is the best non-surgical strategy?喉保留:最佳非手术策略是什么?
Crit Rev Oncol Hematol. 2013 Nov;88(2):447-58. doi: 10.1016/j.critrevonc.2013.05.005. Epub 2013 Jun 5.
6
The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma.化放疗法和挽救性手术治疗下咽鳞状细胞癌的效果。
Jpn J Clin Oncol. 2013 Dec;43(12):1210-7. doi: 10.1093/jjco/hyt136. Epub 2013 Sep 12.
7
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
8
[Non-surgical combined modality treatments for laryngeal organ preservation in advanced hypopharyngeal carcinoma].[晚期下咽癌喉器官保留的非手术综合治疗方法]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jul;49(7):558-63.
9
[Clinical study and survival analysis of combined modality therapies for advanced hypopharyngeal carcinoma].[晚期下咽癌综合治疗的临床研究与生存分析]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Feb;27(4):206-9.
10
[A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].[晚期下咽鳞状细胞癌手术联合或不联合综合治疗的回顾性研究:119例分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 May 7;53(5):352-358. doi: 10.3760/cma.j.issn.1673-0860.2018.05.005.

引用本文的文献

1
Development and Validation of a Prognostic Nomogram for Hypopharyngeal Carcinoma.下咽癌预后列线图的开发与验证
Front Oncol. 2021 Jun 21;11:696952. doi: 10.3389/fonc.2021.696952. eCollection 2021.
2
Magnetic resonance imaging-derived radiomic signature predicts locoregional failure after organ preservation therapy in patients with hypopharyngeal squamous cell carcinoma.磁共振成像衍生的放射组学特征可预测下咽鳞状细胞癌患者接受器官保留治疗后的局部区域复发。
Clin Transl Radiat Oncol. 2020 Aug 31;25:1-9. doi: 10.1016/j.ctro.2020.08.004. eCollection 2020 Nov.
3
A Nomogram for Pretreatment Prediction of Response to Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma.
局部晚期下咽癌诱导化疗反应的预处理预测列线图
Front Oncol. 2020 Dec 11;10:522181. doi: 10.3389/fonc.2020.522181. eCollection 2020.
4
Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.喉鳞状细胞癌:基于免疫相关基因的潜在分子机制及预后特征
Med Sci Monit. 2020 Dec 26;26:e928185. doi: 10.12659/MSM.928185.